Portfolio

Curis

Develops innovative therapeutics targeting cancer network disruption


  • Lexington, MA
  • NASDAQ: CRIS

  • Contact:
    Marty Sutter
  • Formerly Known As: Reprogenesis
  • Acquisition
  • Acquired by: Taseko
  • Exit date: September 08, 2014